Simon Kohl
Latent Labs is pioneering the next frontier of computational biology, building AI foundation models to make biology programmable through de novo protein design. The company’s generative AI platform enables the creation of entirely new proteins from scratch, moving beyond the limitations of naturally occurring proteins to design therapeutic molecules with precisely tailored properties and functions.
Founded by Simon Kohl, a key architect of DeepMind’s Nobel Prize-winning AlphaFold2 system, alongside an all-star team of AI researchers and computational biologists from DeepMind, Google, Microsoft, and leading academic institutions, Latent Labs is realizing the vision of purely computational drug discovery where therapeutic candidates can be generated at the push of a button.
